Whalegun

Insider trades

Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.

Open-market buys
923 trades
$2B in total
Open-market sales
1,038 trades
$2.3B in total
Insiders filing
464 insiders
Last 7 days
Companies with several buyers
26
Last 7 days
OnKure Therapeutics OKUR
Trade type
Nicholas A. SaccomanoPresident and CEO
OnKure TherapeuticsOKUR
Open-market sale09/2109/2387 sh$2.97$258.76−0.8%
Jason A. LeveroneCFO
OnKure TherapeuticsOKUR
Open-market sale09/2109/23302 sh$2.97$898.21−1.6%
Nicholas A. SaccomanoPresident and CEO
OnKure TherapeuticsOKUR
Open-market sale06/2206/2486 sh$4.40$378.4−0.8%
Jason A. LeveroneCFO
OnKure TherapeuticsOKUR
Open-market sale06/2206/24303 sh$4.40$1,333.2−1.6%
Nicholas A. SaccomanoPresident and CEO
OnKure TherapeuticsOKUR
Open-market sale03/2303/2486 sh$4.16$357.76−1.2%
Jason A. LeveroneCFO
OnKure TherapeuticsOKUR
Open-market sale03/2303/24301 sh$4.16$1,252.16−1.8%
Nicholas A. SaccomanoPresident and CEO
OnKure TherapeuticsOKUR
Open-market sale25/12/2225/12/2387 sh$2.97$258.39−1.2%
Jason A. LeveroneCFO
OnKure TherapeuticsOKUR
Open-market sale25/12/2225/12/23302 sh$2.97$896.94−1.8%
Nicholas A. SaccomanoPresident and CEO
OnKure TherapeuticsOKUR
Open-market sale25/09/2225/09/2488 sh$2.62$230.56−2.4%
Jason A. LeveroneCFO
OnKure TherapeuticsOKUR
Open-market sale25/09/2225/09/24303 sh$2.62$793.86−2.3%
Nicholas A. SaccomanoPresident and CEO
OnKure TherapeuticsOKUR
Open-market sale25/06/2325/06/2588 sh$2.38$209.44−2.4%
Jason A. LeveroneCFO
OnKure TherapeuticsOKUR
Open-market sale25/06/2325/06/25303 sh$2.38$721.14−2.3%
10% Owner
OnKure TherapeuticsOKUR
Open-market buy25/05/1525/05/191,400,000 sh2 trades$1.85avg.$2,590,000No record
Cormorant Asset ManagementOther
OnKure TherapeuticsOKUR
Open-market sale25/05/1525/05/191,813,439 sh$1.85$3,354,862.15−100.0%
Bihua ChenOther
OnKure TherapeuticsOKUR
Open-market sale25/05/1525/05/191,813,439 sh$1.85$3,354,862.15−100.0%
Cormorant Global Healthcare Master FundOther
OnKure TherapeuticsOKUR
Open-market sale25/05/1525/05/191,813,439 sh$1.85$3,354,862.15−100.0%
10% Owner
OnKure TherapeuticsOKUR
Open-market buy25/05/1525/05/191,400,000 sh2 trades$1.85avg.$2,590,000No record
10% Owner
OnKure TherapeuticsOKUR
Open-market buy25/05/1525/05/191,400,000 sh2 trades$1.85avg.$2,590,000No record
Cormorant Private Healthcare Fund IIIOther
OnKure TherapeuticsOKUR
Open-market sale25/05/1525/05/191,813,439 sh$1.85$3,354,862.15−100.0%
Cormorant Private Healthcare Fund IVOther
OnKure TherapeuticsOKUR
Open-market sale25/05/1525/05/191,813,439 sh$1.85$3,354,862.15−100.0%